封面
市场调查报告书
商品编码
1600579

心臟安全服务市场:按服务类型、类型和最终用户划分 - 全球预测 2025-2030

Cardiac Safety Services Market by Service Type (Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services), Type (Integrated Services, Standalone Services), End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟安全服务市场价值为12.2亿美元,预计到2024年将达到13.4亿美元,复合年增长率为10.91%,到2030年将达到25.2亿美元。

心臟安全服务包括各种评估和监测过程,旨在确保药物化合物,尤其是新药,不会对心臟功能产生不利影响。这些服务对于确保药物开发阶段(主要是临床前测试期间)的法规遵循和保护病患安全至关重要。其应用涵盖广泛的最终用途产业,包括製药、生物技术和 CRO(委外研发机构)。 FDA 和 EMA 等机构的严格监管要求推动了对心臟安全服务的需求,这些机构要求在核准药物上市之前进行全面的心臟筛检。心血管疾病盛行率的增加、对患者安全的日益关注以及药物开发复杂性的增加对市场产生了重大影响。临床试验活动和生物相似药上市的激增进一步推动了对这些服务的需求。主要成长动力包括影像处理和分析技术的进步,这些技术提高了心臟安全评估的效率和准确性。然而,其局限性包括高昂的营运成本、监管挑战以及需要熟练解读复杂心臟资料的专家。人工智慧和机器学习的整合存在新的机会,可以简化心臟安全通讯协定并减少人为错误。鼓励公司投资开发即时监测技术和个人化医疗方法,以满足个别患者的需求。向新兴国家拓展服务的潜力巨大。儘管该行业仍然以成长为导向,但企业必须克服不断变化的法规和市场参与者整合等挑战。我们对诊断创新以及与技术合作伙伴的合作的关注将使我们在这个不断变化的市场格局中获得竞争优势。

主要市场统计
基准年[2023] 12.2亿美元
预测年份 [2024] 13.4亿美元
预测年份 [2030] 25.2亿美元
复合年增长率(%) 10.91%

市场动态:快速发展的心臟安全服务市场的关键市场洞察

供需的动态交互作用正在改变心臟安全服务市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 心血管疾病盛行率上升以及对有效和安全治疗的需求
    • 使用生物相似药和生物标记检测心臟毒性或心血管风险
    • 政府鼓励循环系统领域个人化治疗的倡议
  • 市场限制因素
    • 心臟评估服务的成本相对较高,且熟练专业人员的数量有限
  • 市场机会
    • 心臟安全测试和监测系统的进步
    • 增加心臟治疗的临床试验与研发
  • 市场挑战
    • 各国缺乏监管标准化

波特五力:驾驭心臟安全服务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战,以确保更强大的市场地位。

PESTLE分析:了解心臟安全服务市场的外部影响

外部宏观环境因素在塑造心臟安全服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟安全服务市场的竞争格局

心臟安全服务市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟安全服务市场供应商的绩效评估

FPNV 定位矩阵是评估心臟安全服务市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商,帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析:

1. 市场渗透率:对当前市场环境的详细回顾,包括行业主要企业的大量资料。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病发生率上升以及有效和安全治疗的需求
      • 使用生物相似药和生物标记检测心臟毒性或心血管风险
      • 政府鼓励心臟病学个人化治疗的倡议
    • 抑制因素
      • 心臟评估服务的成本相对较高,且缺乏熟练的专业人员。
    • 机会
      • 心臟安全测试和监测系统的进步
      • 增加心臟治疗的临床试验与研发
    • 任务
      • 各国缺乏监管标准化
  • 市场区隔分析
    • 服务类型:对高效心血管影像服务的需求不断增加
    • 类型:扩大综合心臟安全服务在药物开发的使用
    • 最终用户:製药和生物製药公司对心臟安全服务的采用激增
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章心臟安全服务市场:依服务类型

  • 血压测量服务
  • 心血管影像服务
  • 心电图或动态心电图测量服务
  • 全面的 QT 研究

第七章心臟安全服务市场:依类型

  • 综合服务
  • 独立服务

第八章心臟安全服务市场:依最终用户分类

  • 合约调查机构
  • 製药和生物製药公司

第九章美洲心臟安全服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太心臟安全服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲心臟安全服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • OSF Healthcare 与 Bellin Health 合作扩大Delta县的心血管服务
    • Jubilant Radiopharma 和 Cardiac Imaging, Inc. 宣布建立独家合作伙伴关係,以扩大行动心臟 PET 服务的覆盖范围
    • GE Healthcare 推出适用于心血管疾病患者的 Vscan Air SL 设备
    • Clario 和 AliveCor 合作提供先进的、特定于试验的 6 导程心电图解决方案,用于分散式临床试验监测
    • Metrion Biosciences 宣布推出 GLP hERG筛检服务
    • Heartnet 推出远距心臟病学产品 ASAAN
    • AliveCor 和 Luscii 合作开发“Heart Clinic In a Box”
    • Abbott 全球首款双腔室无导线心律调节器获得 FDA核准
    • 飞利浦和 Biotronic 合作扩大院外心臟病学实验室的护理
    • 雅培完成对心血管系统公司 8.9 亿美元的收购
    • 飞利浦和 TriHealth 宣布在贝塞斯达北医院园区新 TriHealth 心血管研究所的核心区域建立多年伙伴关係
    • 巴努克集团开设美国办事处,并持续全球扩张

公司名单

  • Lunit Inc.
  • NEXEL Co., Ltd.
  • Tempus Labs, Inc.
  • Certara, Inc.
  • Toray Medical Company Limited by Toray Industries
  • Metrion Biosciences Limited
  • Circle Cardiovascular Imaging Inc.
  • Medpace, Inc.
  • Butterfly Network Inc.
  • GE HealthCare Technologies Inc.
  • Ncardia Services BV
  • Shanghai Medicilon Inc.
  • Thermo Fisher Scientific Inc.
  • Octagos Health, Inc.
  • Richmond Pharmacology Limited
  • Banook Group
  • IQVIA Holdings Inc.
  • Abbott Laboratories
  • Koninklijke Philips NV
  • Clario
  • Siemens Healthcare GmbH
  • PhysioStim SAS
  • Biotrial
  • MERIT CRO, Inc.
  • Dozee
  • AliveCor, Inc.
  • Laboratory Corporation of America Holdings
  • Clyde Biosciences Limited
  • Eurofins Scientific SE
  • ICON PLC
  • Celerion
Product Code: MRR-034230D3E2D5

The Cardiac Safety Services Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.34 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 2.52 billion by 2030.

Cardiac Safety Services encompass a range of assessments and monitoring processes designed to ensure that pharmaceutical compounds, especially new drugs, do not adversely affect the heart's function. These services are crucial in drug development phases, primarily during preclinical trials, to ensure regulatory compliance and protect patient safety. Their application spans a wide range of end-use industries, including pharmaceuticals, biotechnology, and CROs (Contract Research Organizations). The necessity of cardiac safety services is driven by stringent regulatory mandates from bodies like the FDA and EMA, which require comprehensive cardiac screening before a drug can be approved for market release. The market is heavily influenced by the increasing prevalence of cardiovascular diseases, heightened focus on patient safety, and the growing complexities of drug development. A surge in clinical trial activities and biosimilar launches further propels the demand for these services. Key growth drivers include advancements in imaging and analytics technology, enhancing the efficiency and accuracy of cardiac safety assessments. However, the market faces limitations such as high operational costs, regulatory challenges, and the need for skilled professionals proficient in interpreting complex cardiac data. Emerging opportunities exist in the integration of artificial intelligence and machine learning, aiming to streamline cardiac safety protocols and reduce human error. Businesses are recommended to invest in developing real-time monitoring technologies and personalized medicine approaches, catering to individual patient needs. There's a notable potential in expanding services to developing countries, where the market penetration of cardiac safety services is still low. While the industry remains growth-oriented, companies must navigate challenges such as evolving regulations and the consolidation of market players. A focus on innovation in diagnostic methods and collaboration with technological partners will provide a competitive edge in this evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.34 billion
Forecast Year [2030] USD 2.52 billion
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Safety Services Market

The Cardiac Safety Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cardiovascular disorders and the need for effective & safe treatment
    • Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
    • Government initiatives encouraging personalized treatments in cardiology
  • Market Restraints
    • Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
  • Market Opportunities
    • Advancements in cardiac safety testing and monitoring systems
    • Growing number of clinical trials and R&D for cardiac treatments
  • Market Challenges
    • Lack of regulatory standardization across various countries

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Safety Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Safety Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Safety Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Safety Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Safety Services Market

A detailed market share analysis in the Cardiac Safety Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Safety Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Safety Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include Lunit Inc., NEXEL Co., Ltd., Tempus Labs, Inc., Certara, Inc., Toray Medical Company Limited by Toray Industries, Metrion Biosciences Limited, Circle Cardiovascular Imaging Inc., Medpace, Inc., Butterfly Network Inc., GE HealthCare Technologies Inc., Ncardia Services B.V., Shanghai Medicilon Inc., Thermo Fisher Scientific Inc., Octagos Health, Inc., Richmond Pharmacology Limited, Banook Group, IQVIA Holdings Inc., Abbott Laboratories, Koninklijke Philips N.V., Clario, Siemens Healthcare GmbH, PhysioStim SAS, Biotrial, MERIT CRO, Inc., Dozee, AliveCor, Inc., Laboratory Corporation of America Holdings, Clyde Biosciences Limited, Eurofins Scientific SE, ICON PLC, and Celerion.

Market Segmentation & Coverage

This research report categorizes the Cardiac Safety Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service Type, market is studied across Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services, and Thorough QT Studies.
  • Based on Type, market is studied across Integrated Services and Standalone Services.
  • Based on End-User, market is studied across Contract Research Organizations and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cardiovascular disorders and the need for effective & safe treatment
      • 5.1.1.2. Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
      • 5.1.1.3. Government initiatives encouraging personalized treatments in cardiology
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in cardiac safety testing and monitoring systems
      • 5.1.3.2. Growing number of clinical trials and R&D for cardiac treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory standardization across various countries
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Service Type: Proliferating need for efficient cardiovascular imaging services
    • 5.2.2. Type: Expanding use of integrated cardiac safety services for drug development
    • 5.2.3. End-User: Surging adoption of cardiac safety services by pharmaceutical & biopharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Cardiac Safety Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Blood Pressure Measurement Services
  • 6.3. Cardiovascular Imaging Services
  • 6.4. ECG or Holter Measurement Services
  • 6.5. Thorough QT Studies

7. Cardiac Safety Services Market, by Type

  • 7.1. Introduction
  • 7.2. Integrated Services
  • 7.3. Standalone Services

8. Cardiac Safety Services Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Research Organizations
  • 8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas Cardiac Safety Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiac Safety Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Safety Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. OSF HealthCare Establishes a Partnership with Bellin Health to Expand Cardiovascular Services in Delta County
    • 12.3.2. Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
    • 12.3.3. GE HealthCare Announces Vscan Air SL Device for Cardiac, Vascular Patients
    • 12.3.4. Clario and AliveCor Collaborate to Offer Advanced, Trial-Focused Six-Lead ECG Solutions for Monitoring in Decentralized Clinical Trials
    • 12.3.5. Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service
    • 12.3.6. Heartnet Launches Telecardiology Product ASAAN
    • 12.3.7. AliveCor, Luscii Partner On 'Heart Clinic In a Box'
    • 12.3.8. Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
    • 12.3.9. Philips, Biotronik Partner to Expand Care for Out-of-Hospital Cardiology Labs
    • 12.3.10. Abbott Completes USD 890 Million Acquisition of Cardiovascular Systems
    • 12.3.11. Philips and TriHealth Announce Multi-Year Partnership at Heart of New Trihealth Heart & Vascular Institute on the Campus of Bethesda North Hospital
    • 12.3.12. Banook Group Continues Global Expansion with the U.S. Office Opening

Companies Mentioned

  • 1. Lunit Inc.
  • 2. NEXEL Co., Ltd.
  • 3. Tempus Labs, Inc.
  • 4. Certara, Inc.
  • 5. Toray Medical Company Limited by Toray Industries
  • 6. Metrion Biosciences Limited
  • 7. Circle Cardiovascular Imaging Inc.
  • 8. Medpace, Inc.
  • 9. Butterfly Network Inc.
  • 10. GE HealthCare Technologies Inc.
  • 11. Ncardia Services B.V.
  • 12. Shanghai Medicilon Inc.
  • 13. Thermo Fisher Scientific Inc.
  • 14. Octagos Health, Inc.
  • 15. Richmond Pharmacology Limited
  • 16. Banook Group
  • 17. IQVIA Holdings Inc.
  • 18. Abbott Laboratories
  • 19. Koninklijke Philips N.V.
  • 20. Clario
  • 21. Siemens Healthcare GmbH
  • 22. PhysioStim SAS
  • 23. Biotrial
  • 24. MERIT CRO, Inc.
  • 25. Dozee
  • 26. AliveCor, Inc.
  • 27. Laboratory Corporation of America Holdings
  • 28. Clyde Biosciences Limited
  • 29. Eurofins Scientific SE
  • 30. ICON PLC
  • 31. Celerion

LIST OF FIGURES

  • FIGURE 1. CARDIAC SAFETY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC SAFETY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC SAFETY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC SAFETY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY BLOOD PRESSURE MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CARDIOVASCULAR IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY ECG OR HOLTER MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY THOROUGH QT STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY INTEGRATED SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY STANDALONE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023